🇺🇸 Budesonide / Formoterol in United States

25,634 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 25,634

Most-reported reactions

1. Dyspnoea — 4,707 reports (18.36%)
2. Asthma — 4,694 reports (18.31%)
3. Wheezing — 3,098 reports (12.09%)
4. Therapeutic Product Effect Incomplete — 2,383 reports (9.3%)
5. Cough — 2,137 reports (8.34%)
6. Loss Of Personal Independence In Daily Activities — 2,051 reports (8%)
7. Death — 2,043 reports (7.97%)
8. Sleep Disorder Due To A General Medical Condition — 1,727 reports (6.74%)
9. Drug Ineffective — 1,478 reports (5.77%)
10. Pneumonia — 1,316 reports (5.13%)

Source database →

Frequently asked questions

Is Budesonide / Formoterol approved in United States?

Budesonide / Formoterol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Budesonide / Formoterol in United States?

Brigham and Women's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.